TASO-001

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameTASO-001

Drug Alias NameTGF-β2 targeting anti-sense oligonucleotide - Autotelic BioTASO-001ATB-301

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionTransforming growth factor beta receptor 2 modulators

TargetsTransforming growth factor beta receptor 2

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAutotelicbio Co Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A